International Urology and Nephrology

, Volume 50, Issue 5, pp 845–850 | Cite as

Elevated visceral obesity quantified by CT is associated with adverse postoperative outcome of laparoscopic radical nephrectomy for renal clear cell carcinoma patients

  • Tingshuai Zhai
  • Bocheng Zhang
  • Zhenan Qu
  • Chen Chen
Urology - Original Paper



To examine the association between CT measures of visceral obesity and short-term postoperative outcomes in renal clear cell carcinoma (RCCC) patients.


In this retrospective study, 76 patients treated with unilateral laparoscopic radical nephrectomy for stage I–III renal cancer were classified as obese or non-obese by preoperative CT-based measures of adiposity [obese: visceral fat area (VFA) > 100 cm2, BMI ≥ 28 kg/m2]. Clinical variables, Fuhrman grade, operation time, estimated blood loss (EBL), postoperative complications, postoperative stay, drainage time and hospitalization expenses were compared between the two groups.


Viscerally obese patients significantly had higher Fuhrman grade than the non-obese (p = 0.018). The operation time of obese patients by VFA or BMI was more than the non-obese (171.6 ± 68.9 vs. 140.8 ± 35.5 min, p = 0.012 and 197.2 ± 67.2 vs. 153.2 ± 57.7 min, p = 0.013, respectively). And obese patients by VFA or BMI tended to have more EBL than non-obese (132.0 ± 120.7 vs. 83.8 ± 53.4 ml, p = 0.018 and 215.3 ± 165.0 vs. 92.5 ± 68.8 ml, p = 0.013, respectively). Viscerally obese patients by VFA (not BMI) were more likely to develop postoperative complications as compared to patients classified as non-obese: VFA (26.9 vs. 4.2%, p = 0.045) and BMI (33.3 vs. 16.4%, p =0.265). Furthermore, obese patients by VFA (not BMI) were more likely to have longer postoperative stay: VFA (8.7 ± 2.5 vs. 7.5 ± 1.4 dollars, p = 0.013) and BMI (9.1 ± 2.9 vs. 8.1 ± 2.1 dollars, p = 0.209). Obese patients expensed more than non-obese: VFA (7570.9 ± 2674.3 vs. 6368.8 ± 1289.8 dollars, p = 0.040) and BMI (8390.8 ± 2929.7 vs. 6896.3 ± 2159.1 dollars, p = 0.029).


Elevated visceral obesity by VFA is associated with increased surgical complexity, postoperative morbidity, postoperative stay and hospitalization expenses for RCCC patients and may be superior to BMI for renal cancer outcome assessment. VFA may be a useful index for the evaluation and calculation of RCCC aggressiveness.


Renal clear cell carcinoma Visceral obesity Computed tomography Surgical complications Postoperative outcome 



Tingshuai Zhai contributed to study design, data collection, analysis, and writing. Bocheng Zhang involved in data collection, design, and writing. Zhenan Qu and Chen Chen contributed to data collection and design. Tingshuai Zhai thanks the care and guidance of Dr. Weizheng Mao, Dr. Bo Jiang and Dr. Sichuan Hou.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.


  1. 1.
    Ozoya OO, Siegel EM, Srikumar T et al (2017) Quantitative assessment of visceral obesity and postoperative colon cancer outcomes. Gastrointest Surg 21(3):534–542CrossRefGoogle Scholar
  2. 2.
    Yuge K, Miyajima A, Jinzaki M et al (2015) How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy? Jpn J Clin Oncol 45(4):373–377CrossRefPubMedGoogle Scholar
  3. 3.
    Keehn A, Srivastava A, Maiman R et al (2015) The relationship between visceral obesity and the clinicopathologic features of patients with small renal masses. J Endourol 29(3):372–376CrossRefPubMedGoogle Scholar
  4. 4.
    Irving BA, Weltman JY, Brock DWNIH et al (2007) ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissue. Obesity (Silver Spring) 15(2):370–376CrossRefGoogle Scholar
  5. 5.
    Sobin LH, Gospodariwicz M, Wittekind C (eds) (2009) TNM classification of malignant tumors. UICC International Union Against Cancer, vol 7. Wiley-Blackwell, Hoboken, p 255Google Scholar
  6. 6.
    Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Jeong IG, Khandwala YS, Kim JH et al (2017) Association of robotic-assisted vs laparoscopic radical nephrectomy with perioperative outcomes and health care costs, 2003 to 2015. JAMA 318(16):1561–1568CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Finnerty CC, Mabvuure NT, Ali A et al (2013) The surgically induced stress response. JPEN J Parenter Enteral Nutr 37(5 Suppl):21S–29SCrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Tewari N, Awad S, Macdonald IA, Lobo DN (2015) Obesity-related insulin resistance: implications for the surgical patient. Int J Obes (Lond) 39(11):1575–1588CrossRefGoogle Scholar
  10. 10.
    Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 1229:45–52CrossRefPubMedGoogle Scholar
  11. 11.
    Klöting N, Fasshauer M, Dietrich A et al (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299(3):E506–E515CrossRefPubMedGoogle Scholar
  12. 12.
    Ye J, Gao Z, Yin J et al (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293(4):E1118–E1128CrossRefPubMedGoogle Scholar
  13. 13.
    Qin L, Wang Z, Tao L et al (2010) ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy. Autophagy 6(2):239–247CrossRefPubMedGoogle Scholar
  14. 14.
    Pecorelli N, Carrara G, DeCobelli F et al (2016) Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg 103(4):434–442CrossRefPubMedGoogle Scholar
  15. 15.
    Hagiwara M, Miyajima A, Hasegawa M et al (2012) Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy. BJU Int 110(11 Pt C):E980-4PubMedGoogle Scholar
  16. 16.
    Ioffe E, Hakimi AA, Sk O et al (2013) Effect of visceral obesity on minimally invasive partial nephrectomy. Urology 82(3):612–618CrossRefPubMedGoogle Scholar
  17. 17.
    Zhu Y, Wang HK, Zhang HL et al (2013) Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma. J Urol 189(2):447–453CrossRefPubMedGoogle Scholar
  18. 18.
    Kato M, Suzuki T, Suzuki Y et al (2004) Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol 172:863CrossRefPubMedGoogle Scholar
  19. 19.
    Guðmundsson E, Hellborg H, Lundstam S et al (2011) Metastatic potential in renal cell carcinomas ≤ 7 cm: Swedish kidney cancer quality register data. Eur Urol 60:975CrossRefPubMedGoogle Scholar
  20. 20.
    Khandekar MJ, Cohen P, Spiegelman BM et al (2011) Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11:886CrossRefPubMedGoogle Scholar
  21. 21.
    Cao Y (2007) Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117:2362–2368CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Ladoire S, Bonnetain F, Gauthier M et al (2011) Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents. Oncologist 16:71–81CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Yerlikaya A, Dagel T, King C et al (2017) Dietary and commercialized fructose: Sweet or sour? Int Urol Nephrol 49:1611CrossRefPubMedGoogle Scholar
  24. 24.
    Kadowaki T, Sekikawa A, Murata K et al (2006) Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int J Obes (Lond) 30:1163CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Dalian Medical UniversityDalianChina

Personalised recommendations